The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
The degeneration of midbrain dopaminergic (mDA) neurons, particularly in the substantia nigra pars compacta (SNc), is one of the most prominent pathological hallmarks of Parkinson’s disease (PD). To uncover the pathogenic mechanisms of mDA neuronal death during PD may provide therapeutic targets to...
Main Authors: | Xin Wang, Xi Chen, Guangdong Liu, Huaibin Cai, Weidong Le |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/10/8614 |
Similar Items
-
Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
by: Nicola J. Drummond, et al.
Published: (2020-11-01) -
PITX3 variants in Chinese patients with Parkinson’s disease
by: Philipp G Sand, et al.
Published: (2014-01-01) -
From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
by: Yee Jie Yeap, et al.
Published: (2023-01-01) -
The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons
by: Marianna Tolve, et al.
Published: (2021-09-01) -
The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain
by: Walaa F. Alsanie, et al.
Published: (2023-03-01)